Literature DB >> 32918497

Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study.

Philipp Koehler1,2, Oliver A Cornely1,2,3,4, Matthias Kochanek1.   

Abstract

OBJECTIVES: With the outbreak of coronavirus disease 2019 (COVID-19), clinicians have used personal protective equipment to avoid transmission of severe acute respiratory syndrome coronavirus 2. However, they still face occupational risk of infection, when treating COVID-19 patients. This may be highest during invasive diagnostic procedures releasing aerosols and droplets. Thereby, the use of diagnostic procedures for Covid-19 associated aspergillosis may be delayed or impeded, as use of bronchoscopy has been discouraged. This leads to avoidance of a crucial procedure for diagnosing invasive aspergillosis. We intent to visualise aerosol and droplet spread and surface contamination during bronchoscopy and address which measures can avoid exposure of health-care workers.
METHODS: We created a simulation model to visualise aerosol and droplet generation as well as surface contamination by nebulising fluorescent solution detected by using ultraviolet light- and slow-motion capture. We repurposed covers for ultrasound transducers or endoscopic cameras to prevent surface and ambient air contamination.
RESULTS: In our bronchoscopy simulation model, we noticed extensive aerosol generation, droplet spread and surface contamination. Exposure of health-care workers and contamination of surfaces can be efficiently reduced by repurposing covers for ultrasound transducers or endoscopic cameras to seal the tube opening during bronchoscopy in mechanically ventilated patients.
CONCLUSION: Adequate personal protective equipment and safety strategies allow to minimise contamination during bronchoscopy in mechanically ventilated COVID-19 patients.
© 2020 The Authors. Mycoses published by Wiley-VCH GmbH.

Entities:  

Keywords:  Coronavirus; SARS-CoV-2; contamination; health-care workers; nosocomial infection

Mesh:

Year:  2020        PMID: 32918497     DOI: 10.1111/myc.13183

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  11 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 2.  Ten decadal advances in fungal biology leading towards human well-being.

Authors:  Ausana Mapook; Kevin D Hyde; Khadija Hassan; Blondelle Matio Kemkuignou; Adéla Čmoková; Frank Surup; Eric Kuhnert; Pathompong Paomephan; Tian Cheng; Sybren de Hoog; Yinggai Song; Ruvishika S Jayawardena; Abdullah M S Al-Hatmi; Tokameh Mahmoudi; Nadia Ponts; Lena Studt-Reinhold; Florence Richard-Forget; K W Thilini Chethana; Dulanjalee L Harishchandra; Peter E Mortimer; Huili Li; Saisamorm Lumyong; Worawoot Aiduang; Jaturong Kumla; Nakarin Suwannarach; Chitrabhanu S Bhunjun; Feng-Ming Yu; Qi Zhao; Doug Schaefer; Marc Stadler
Journal:  Fungal Divers       Date:  2022-09-15       Impact factor: 24.902

Review 3.  Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19.

Authors:  Maddalena Peghin; Antonio Vena; Elena Graziano; Daniele Roberto Giacobbe; Carlo Tascini; Matteo Bassetti
Journal:  Ther Adv Infect Dis       Date:  2022-05-14

4.  Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.

Authors:  Hayato Mitaka; Toshiki Kuno; Hisato Takagi; Paru Patrawalla
Journal:  Mycoses       Date:  2021-05-06       Impact factor: 4.931

Review 5.  Bronchoscopy simulation training in the post-pandemic world.

Authors:  Lais Meirelles Nicoliello Vieira; Paulo Augusto Moreira Camargos; Cássio da Cunha Ibiapina
Journal:  J Bras Pneumol       Date:  2022-04-29       Impact factor: 2.624

Review 6.  Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature.

Authors:  Mohammadreza Salehi; Nasim Khajavirad; Arash Seifi; Faeze Salahshour; Behnaz Jahanbin; Hossein Kazemizadeh; Sayed Jamal Hashemi; Seyed Ali Dehghan Manshadi; Mohammad Kord; Paul E Verweij; Sadegh Khodavaisy
Journal:  Mycoses       Date:  2021-03-02       Impact factor: 4.931

7.  COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital.

Authors:  García-Clemente Marta; Forcelledo-Espina Lorena; Martínez-Vega Laura; Lanza-Martínez Angela; Leoz-Gordillo Blanca; Albillos-Almaraz Rodrigo; Solís-García Marta; Melón-García Santiago; Pérez-Martínez Liliana; Sánchez-Nuñez Maria Luisa; Peláez-García de la Rasilla Teresa
Journal:  J Fungi (Basel)       Date:  2022-01-19

Review 8.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

9.  Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.

Authors:  Carla M Roman-Montes; Areli Martinez-Gamboa; Paulette Diaz-Lomelí; Axel Cervantes-Sanchez; Andrea Rangel-Cordero; Jose Sifuentes-Osornio; Alfredo Ponce-de-Leon; Maria F Gonzalez-Lara
Journal:  Mycoses       Date:  2021-02-13       Impact factor: 4.931

10.  Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

Authors:  Paul E Verweij; Roger J M Brüggemann; Elie Azoulay; Matteo Bassetti; Stijn Blot; Jochem B Buil; Thierry Calandra; Tom Chiller; Cornelius J Clancy; Oliver A Cornely; Pieter Depuydt; Philipp Koehler; Katrien Lagrou; Dylan de Lange; Cornelia Lass-Flörl; Russell E Lewis; Olivier Lortholary; Peter-Wei Lun Liu; Johan Maertens; M Hong Nguyen; Thomas F Patterson; Bart J A Rijnders; Alejandro Rodriguez; Thomas R Rogers; Jeroen A Schouten; Joost Wauters; Frank L van de Veerdonk; Ignacio Martin-Loeches
Journal:  Intensive Care Med       Date:  2021-06-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.